NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Statera Biopharma Inc (NASDAQ: STAB)
STAB Technical Analysis
5
As on 9th Jun 2023 STAB STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.52 & Strong Sell for SHORT-TERM with Stoploss of 1.43 we also expect STOCK to react on Following IMPORTANT LEVELS. |
STABSTOCK Price
Open | 0.03 | Change | Price | % |
High | 0.04 | 1 Day | 0.00 | 0.00 |
Low | 0.02 | 1 Week | 0.00 | 0.00 |
Close | 0.03 | 1 Month | 0.01 | 50.00 |
Volume | 89886 | 1 Year | -2.21 | -98.66 |
52 Week High 2.30 | 52 Week Low 0.01 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
STAB Daily Charts |
STAB Intraday Charts |
Whats New @ Bazaartrend |
STAB Free Analysis |
|
STAB Important Levels Intraday
RESISTANCE | 0.07 |
RESISTANCE | 0.06 |
RESISTANCE | 0.05 |
RESISTANCE | 0.04 |
SUPPORT | 0.02 |
SUPPORT | 0.01 |
SUPPORT | 0.00 |
SUPPORT | -0.01 |
STAB Forecast May 2024
4th UP Forecast | 2.5 |
3rd UP Forecast | 1.71 |
2nd UP Forecast | 1.22 |
1st UP Forecast | 0.73 |
1st DOWN Forecast | -0.67 |
2nd DOWN Forecast | -1.16 |
3rd DOWN Forecast | -1.65 |
4th DOWN Forecast | -2.44 |
STAB Weekly Forecast
4th UP Forecast | 0.63 |
3rd UP Forecast | 0.44 |
2nd UP Forecast | 0.32 |
1st UP Forecast | 0.20 |
1st DOWN Forecast | -0.14 |
2nd DOWN Forecast | -0.26 |
3rd DOWN Forecast | -0.38 |
4th DOWN Forecast | -0.57 |
STAB Forecast2024
4th UP Forecast | 4.67 |
3rd UP Forecast | 3.18 |
2nd UP Forecast | 2.26 |
1st UP Forecast | 1.34 |
1st DOWN Forecast | -1.28 |
2nd DOWN Forecast | -2.2 |
3rd DOWN Forecast | -3.12 |
4th DOWN Forecast | -4.61 |
Statera Biopharma Inc ( NASDAQ USA Symbol : STAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
STAB Other Details
Segment | EQ | |
Market Capital | 119703376.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
STAB Address
STAB Latest News
STAB Business Profile
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service